Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Lymphoma × Clozapine × Other hematologic neoplasm × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Lymphoid 1

Conditions

Lymphoma 1 Leukemia 1

Interventions

Cyclophosphamide 196 fludarabine phosphate 104 Rituximab 97 Filgrastim 91 Etoposide 78 Peripheral Blood Stem Cell Transplantation 75 fludarabine 72 Radiotherapy 71 Busulfan 69 Melphalan 67 Methotrexate 62 Tacrolimus 60 Mycophenolic Acid 59 Cytarabine 59 Antilymphocyte Serum 53 Whole-Body Irradiation 52 Cyclosporine 47 Vincristine 42 Prednisone 36 Doxorubicin 36 Methylprednisolone 29 Granulocyte Colony-Stimulating Factor 29 Cord Blood Stem Cell Transplantation 26 Dexamethasone 25 Stem Cell Transplantation 23 Carmustine 23 Alemtuzumab 23 sargramostim 21 Thiotepa 21 thymoglobulin 19

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04074213 2019-08-30

CLOZARIX

University Hospital, Caen

1,000,000 enrolled

LymphoidOther hematologic neoplasm

Leukemia, Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡